DoW Alzheimer?s Transforming Care Award

The DoW Alzheimer’s Transforming Care Award supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s). The award has several distinctive features, including the allowance of clinical research and clinical trials, the requirement of preliminary data, and the encouragement of community collaboration and the leveraging of existing cohorts/datasets. Key points to consider: • Clinical research and clinical trials are allowed, but clinical trials solely testing pharmacological interventions do not meet the intent of this funding opportunity. • Studies utilizing animal models do not meet the intent of the mechanism and are not allowed. • Preliminary data are required. • Community collaboration is required for research prospectively enrolling human subjects. • The AZRP encourages studies to leverage existing cohorts/datasets. • The Career Initiation or Transition (CIT) Partnership Option is available, supporting both new and existing collaborative partnerships.